Tebentafusp-tebn With LDT in Metastatic UM — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Tebentafusp-tebn With LDT in Metastatic UM — Stella

Home/Metastatic Uveal Melanoma/

View on ClinicalTrials.gov

Recruiting

Back to Metastatic Uveal Melanoma trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Thomas Jefferson University, Philadelphia, Pennsylvania

Key details

Phase

Early testing / Safety & dosing

Sponsor

Thomas Jefferson University

Collaborators

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Enrollment target

~109 participants

Started

October 2025

Primary completion

October 2030

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

18 Years and older

Last updated November 2025